Boddu Srikanth, Dinkin Marc, Suurna Maria, Hannsgen Kelly, Bui Xem, Patsalides Athos
Department of Neurological surgery, Division of Interventional Neuroradiology, New York Presbyterian Hospital / Weill Cornell Medical Center, New York, New York, United States of America.
Department of Ophthalmology, New York Presbyterian Hospital / Weill Cornell Medical Center, New York, New York, United States of America.
PLoS One. 2016 Oct 21;11(10):e0164466. doi: 10.1371/journal.pone.0164466. eCollection 2016.
Evaluate the role of venous sinus stenting in the treatment of pulsatile tinnitus among patients with Idiopathic Intracranial Hypertension (IIH) and significant venous sinus stenosis.
A written informed consent approved by the Weill Cornell institutional review board was signed and obtained from the study participants. Thirty-seven consecutive patients with IIH and venous sinus stenosis who were treated with venous sinus stenting between Jan.2012-Jan.2016 were prospectively evaluated. Patients without pulsatile tinnitus were excluded. Tinnitus severity was categorized based on "Tinnitus Handicap Inventory" (THI) at pre-stent, day-0, 1-month, 3-month, 6-month, 12-month, 18-month and 2-year follow-up. Demographics, body-mass index (BMI), pre and post VSS trans-stenotic pressure gradient were documented. Statistical analysis performed using Pearson's correlation, Chi-square analysis and Fischer's exact test.
29 patients with a mean age of 29.5±8.5 years M:F = 1:28. Median (mean) THI pre and post stenting were: 4 (3.7) and 1 (1) respectively. Median time of tinnitus resolution post VSS was 0-days. There was significant improvement of THI (Δ Mean: 2.7 THI [95% CI: 2.3-3.1 THI], p<0.001) and transverse-distal sigmoid sinus gradient (Δ Mean: -15.3 mm Hg [95% CI: 12.7-18 mm Hg], p<0.001) post-stenting. Mean follow-up duration of 26.4±9.8 months (3-44 months). VSS was feasible in 100% patients with no procedural complications. Three-patients (10%) had recurrent sinus stenosis and tinnitus at mean follow-up of 12 months (6-30 months).
Venous sinus stenting is an effective treatment for pulsatile tinnitus in patients with IIH and venous sinus stenosis.
评估静脉窦支架置入术在特发性颅内高压(IIH)合并明显静脉窦狭窄患者搏动性耳鸣治疗中的作用。
研究参与者签署并获得了威尔康奈尔机构审查委员会批准的书面知情同意书。对2012年1月至2016年1月期间连续37例接受静脉窦支架置入术治疗的IIH合并静脉窦狭窄患者进行前瞻性评估。排除无搏动性耳鸣的患者。在支架置入术前、术后第0天、1个月、3个月、6个月、12个月、18个月和2年随访时,根据“耳鸣障碍量表”(THI)对耳鸣严重程度进行分类。记录人口统计学资料、体重指数(BMI)、静脉窦支架置入术前和术后跨狭窄压力梯度。采用Pearson相关性分析、卡方分析和Fisher精确检验进行统计分析。
29例患者,平均年龄29.5±8.5岁,男:女 = 1:28。支架置入术前和术后THI的中位数(均值)分别为:4(3.7)和1(1)。静脉窦支架置入术后耳鸣缓解的中位时间为0天。支架置入术后THI(平均变化:2.7 THI [95%可信区间:2.3 - 3.1 THI],p<0.001)和横窦-乙状窦远端梯度(平均变化:-15.3 mmHg [95%可信区间:12.7 - 18 mmHg],p<0.001)有显著改善。平均随访时间为26.4±9.8个月(3 - 44个月)。100%的患者静脉窦支架置入术可行,无手术并发症。3例患者(10%)在平均12个月(6 - 30个月)的随访中出现复发性窦狭窄和耳鸣。
静脉窦支架置入术是治疗IIH合并静脉窦狭窄患者搏动性耳鸣的有效方法。